401 related articles for article (PubMed ID: 28471965)
1. Nonoverweight nonalcoholic fatty liver disease and incident cardiovascular disease: A post hoc analysis of a cohort study.
Yoshitaka H; Hamaguchi M; Kojima T; Fukuda T; Ohbora A; Fukui M
Medicine (Baltimore); 2017 May; 96(18):e6712. PubMed ID: 28471965
[TBL] [Abstract][Full Text] [Related]
2. Risk of Cardiovascular Disease in Individuals With Nonobese Nonalcoholic Fatty Liver Disease.
Arvind A; Henson JB; Osganian SA; Nath C; Steinhagen LM; Memel ZN; Donovan A; Balogun O; Chung RT; Simon TG; Corey KE
Hepatol Commun; 2022 Feb; 6(2):309-319. PubMed ID: 34558862
[TBL] [Abstract][Full Text] [Related]
3. Ultrasound-Diagnosed Nonalcoholic Fatty Liver Disease Independently Predicts a Higher Risk of Developing Diabetes Mellitus in Nonoverweight Individuals.
Wang L
Acad Radiol; 2019 Jul; 26(7):863-868. PubMed ID: 30254005
[TBL] [Abstract][Full Text] [Related]
4. Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular disease in adult patients with type 1 diabetes.
Mantovani A; Mingolla L; Rigolon R; Pichiri I; Cavalieri V; Zoppini G; Lippi G; Bonora E; Targher G
Int J Cardiol; 2016 Dec; 225():387-391. PubMed ID: 27768965
[TBL] [Abstract][Full Text] [Related]
5. The impact of non-alcoholic fatty liver disease on incident type 2 diabetes mellitus in non-overweight individuals.
Fukuda T; Hamaguchi M; Kojima T; Hashimoto Y; Ohbora A; Kato T; Nakamura N; Fukui M
Liver Int; 2016 Feb; 36(2):275-83. PubMed ID: 26176710
[TBL] [Abstract][Full Text] [Related]
6. Skeletal muscle mass and abdominal obesity are independent predictors of hepatic steatosis and interact to predict ten-year cardiovascular disease incidence: Data from the ATTICA cohort study.
Kouvari M; Polyzos SA; Chrysohoou C; Skoumas J; Pitsavos CS; Panagiotakos DB; Mantzoros CS
Clin Nutr; 2022 Jun; 41(6):1281-1289. PubMed ID: 35504171
[TBL] [Abstract][Full Text] [Related]
7. Association between the lean nonalcoholic fatty liver disease and risk of incident type 2 diabetes in a healthy population of Northwest China: a retrospective cohort study with a 2-year follow-up period.
Li N; Xang W; Wu S; Li D; Chang M; Xie C; Zhang MY; Tan H
Front Endocrinol (Lausanne); 2023; 14():1173757. PubMed ID: 37435491
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular risk factors in non-alcoholic fatty liver disease.
Hagström H; Nasr P; Ekstedt M; Hammar U; Stål P; Askling J; Hultcrantz R; Kechagias S
Liver Int; 2019 Jan; 39(1):197-204. PubMed ID: 30253056
[TBL] [Abstract][Full Text] [Related]
9. Risk for the development of non-alcoholic fatty liver disease: A prospective study.
Wang J; Ma L; Chen S; Xu L; Miao M; Yu C; Li Y; Xu C
J Gastroenterol Hepatol; 2018 Aug; 33(8):1518-1523. PubMed ID: 29381226
[TBL] [Abstract][Full Text] [Related]
10. Risk of cardiovascular disease in patients with fatty liver disease as defined from the metabolic dysfunction associated fatty liver disease or nonalcoholic fatty liver disease point of view: a retrospective nationwide claims database study in Japan.
Yoneda M; Yamamoto T; Honda Y; Imajo K; Ogawa Y; Kessoku T; Kobayashi T; Nogami A; Higurashi T; Kato S; Hosono K; Saito S; Nakajima A
J Gastroenterol; 2021 Nov; 56(11):1022-1032. PubMed ID: 34601620
[TBL] [Abstract][Full Text] [Related]
11. Metabolically Healthy Obesity and the Development of Nonalcoholic Fatty Liver Disease.
Chang Y; Jung HS; Cho J; Zhang Y; Yun KE; Lazo M; Pastor-Barriuso R; Ahn J; Kim CW; Rampal S; Cainzos-Achirica M; Zhao D; Chung EC; Shin H; Guallar E; Ryu S
Am J Gastroenterol; 2016 Aug; 111(8):1133-40. PubMed ID: 27185080
[TBL] [Abstract][Full Text] [Related]
12. Fatty Liver Index as a proxy for non-alcoholic fatty liver disease and the risk of stroke and coronary heart disease: The Suita Study.
Arafa A; Kashima R; Matsumoto C; Kokubo Y
J Stroke Cerebrovasc Dis; 2024 Jan; 33(1):107495. PubMed ID: 38000108
[TBL] [Abstract][Full Text] [Related]
13. Metabolic Dysfunction-Associated Fatty Liver Disease and Incident Cardiovascular Disease Risk: A Nationwide Cohort Study.
Lee H; Lee YH; Kim SU; Kim HC
Clin Gastroenterol Hepatol; 2021 Oct; 19(10):2138-2147.e10. PubMed ID: 33348045
[TBL] [Abstract][Full Text] [Related]
14. Short sleep duration is a risk of incident nonalcoholic fatty liver disease: a population-based longitudinal study.
Okamura T; Hashimoto Y; Hamaguchi M; Obora A; Kojima T; Fukui M
J Gastrointestin Liver Dis; 2019 Mar; 28(1):73-81. PubMed ID: 30851175
[TBL] [Abstract][Full Text] [Related]
15. Impact of diabetes on subclinical atherosclerosis and major cardiovascular events in individuals with and without non-alcoholic fatty liver disease.
Wang B; Zhao Z; Liu S; Wang S; Chen Y; Xu Y; Xu M; Wang W; Ning G; Li M; Wang T; Bi Y
Diabetes Res Clin Pract; 2021 Jul; 177():108873. PubMed ID: 34051282
[TBL] [Abstract][Full Text] [Related]
16. Alcoholic and Nonalcoholic Fatty Liver Disease and Incident Hospitalization for Liver and Cardiovascular Diseases.
Chang Y; Cho J; Cho YK; Cho A; Hong YS; Zhao D; Ahn J; Sohn CI; Shin H; Guallar E; Ryu S
Clin Gastroenterol Hepatol; 2020 Jan; 18(1):205-215.e7. PubMed ID: 31085337
[TBL] [Abstract][Full Text] [Related]
17. The preventive effect of sustained physical activity on incident nonalcoholic fatty liver disease.
Kwak MS; Kim D; Chung GE; Kim W; Kim JS
Liver Int; 2017 Jun; 37(6):919-926. PubMed ID: 27917585
[TBL] [Abstract][Full Text] [Related]
18. Non-alcoholic fatty liver disease, metabolic goal achievement with incident cardiovascular disease and eGFR-based chronic kidney disease in patients with prediabetes and diabetes.
Li M; Zhao Z; Qin G; Chen L; Lu J; Huo Y; Chen L; Zeng T; Xu M; Chen Y; Wang T; Wang S; Xu Y; Shi L; Tang X; Su Q; Yu X; Yan L; Wan Q; Chen G; Gao Z; Wang G; Shen F; Luo Z; Zhang Y; Liu C; Wang Y; Hu R; Ye Z; Wu S; Deng H; Yang T; Li Q; Qin Y; Mu Y; Zhao J; Ning G; Bi Y; Xu Y; Wang W
Metabolism; 2021 Nov; 124():154874. PubMed ID: 34517014
[TBL] [Abstract][Full Text] [Related]
19. Association between fasting plasma glucose and nonalcoholic fatty liver disease in a nonobese Chinese population with normal blood lipid levels: a prospective cohort study.
Zou Y; Yu M; Sheng G
Lipids Health Dis; 2020 Jun; 19(1):145. PubMed ID: 32563249
[TBL] [Abstract][Full Text] [Related]
20. Relative fat mass at baseline and its early change may be a predictor of incident nonalcoholic fatty liver disease.
Kim HY; Baik SJ; Lee HA; Lee BK; Lee HS; Kim TH; Yoo K
Sci Rep; 2020 Oct; 10(1):17491. PubMed ID: 33060775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]